Peck L, Borle K, Folkersen L, Austin J. Why do people seek out polygenic risk scores for complex disorders, and how do they understand and react to results? Eur J Hum Genet. 2022;30:81–7.
Google Scholar
Phulka JS, Ashraf M, Bajwa BK, Pare G, Laksman Z. Current State and Future of Polygenic Risk Scores in Cardiometabolic Disease: A Scoping Review. Circ Genom Precis Med. 2023;16:286–313.
Google Scholar
Yang S, Zhou X. Accurate and Scalable Construction of Polygenic Scores in Large Biobank Data Sets. Am J Hum Genet. 2020;106:679–93.
Google Scholar
O’Sullivan JW, Raghavan S, Marquez-Luna C, Luzum JA, Damrauer SM, Ashley EA, et al. Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation [Internet]. 2022. https://doi.org/10.1161/CIR.0000000000001077
Haga SB, Kim E, Myers RA, Ginsburg GS. Primary Care Physicians’ Knowledge, Attitudes, and Experience with Personal Genetic Testing. J Pers Med. 2019;9:29.
Google Scholar
Slunecka JL, Van Der Zee MD, Beck JJ, Johnson BN, Finnicum CT, Pool R, et al. Implementation and implications for polygenic risk scores in healthcare. Hum Genomics. 2021;15:46.
Google Scholar
Suckiel SA, Braganza GT, Aguiñiga KL, Odgis JA, Bonini KE, Kenny EE, et al. Perspectives of diverse Spanish- and English-speaking patients on the clinical use of polygenic risk scores. Genet Med. 2022;24:1217–26.
Google Scholar
Hollitt GL, Siggs OM, Ridge B, Keane MC, Mackey DA, MacGregor S, et al. Attitudes Towards Polygenic Risk Testing in Individuals with Glaucoma. Ophthalmol Glaucoma. 2021;S2589419621002635.
Saya S, McIntosh JG, Winship IM, Milton S, Clendenning M, Kyriakides M, et al. Informed choice and attitudes regarding a genomic test to predict risk of colorectal cancer in general practice. Patient Educ Couns. 2022;105:987–95.
Google Scholar
Smit AK, Sharman AR, Espinoza D, Wallingford C, Young M, Dunlop K, et al. Knowledge, views and expectations for cancer polygenic risk testing in clinical practice: A cross‐sectional survey of health professionals. Clin Genet. 2021;100:430–9.
Google Scholar
Scherr CL, Kalke K, Ramesh S, Fakhari H, Dellefave-Castillo LM, Smith ME, et al. Integrating clinical genetics in cardiology: Current practices and recommendations for education. Genet Med. 2022;24:1054–61.
Google Scholar
Haga SB, Barry WT, Mills R, Ginsburg GS, Svetkey L, Sullivan J, et al. Public Knowledge of and Attitudes Toward Genetics and Genetic Testing. Genet Test Mol Biomark. 2013;17:327–35.
Google Scholar
Kaphingst KA, Blanchard M, Milam L, Pokharel M, Elrick A, Goodman MS. Relationships Between Health Literacy and Genomics-Related Knowledge, Self-Efficacy, Perceived Importance, and Communication in a Medically Underserved Population. J Health Commun. 2016;21:58–68.
Google Scholar
Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 2020;12:44.
Google Scholar
Torkamani A, Wineinger NE, Topol EJ. The personal and clinical utility of polygenic risk scores. Nat Rev Genet. 2018;19:581–90.
Google Scholar
Weinberg DS, Myers RE, Keenan E, Ruth K, Sifri R, Ziring B, et al. Genetic and Environmental Risk Assessment and Colorectal Cancer Screening in an Average-Risk Population: A Randomized Trial. Ann Intern Med. 2014;161:537.
Google Scholar
Silarova B, Sharp S, Usher-Smith JA, Lucas J, Payne RA, Shefer G, et al. Effect of communicating phenotypic and genetic risk of coronary heart disease alongside web-based lifestyle advice: the INFORM Randomised Controlled Trial. Heart. 2019;105:982–9.
Google Scholar
Hollands GJ, French DP, Griffin SJ, Prevost AT, Sutton S, King S, et al. The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis. BMJ. 2016;352:i1102.
Knowles JW, Zarafshar S, Pavlovic A, Goldstein BA, Tsai S, Li J, et al. Impact of a Genetic Risk Score for Coronary Artery Disease on Reducing Cardiovascular Risk: A Pilot Randomized Controlled Study. Front Cardiovasc Med. 2017;4:53.
Google Scholar
Kalia NK, Cespedes L, Youssef G, Li D, Budoff MJ. Motivational effects of coronary artery calcium scores on statin adherence and weight loss. Coron Artery Dis. 2015;26:225–30.
Google Scholar
Mamudu HM, Paul TK, Veeranki SP, Budoff M. The effects of coronary artery calcium screening on behavioral modification, risk perception, and medication adherence among asymptomatic adults: A systematic review. Atherosclerosis. 2014;236:338–50.
Google Scholar
Marteau TM, Weinman J. Self-regulation and the behavioural response to DNA risk information: A theoretical analysis and framework for future research. Soc Sci Med. 2006;62:1360–8.
Google Scholar
Austin J. The effect of genetic test-based risk information on behavioral outcomes: A critical examination of failed trials and a call to action. Am J Med Genet A. 2015;167:2913–5.
Google Scholar
Klarin D, Natarajan P. Clinical utility of polygenic risk scores for coronary artery disease. Nat Rev Cardiol. 2022;19:291–301.
Google Scholar
Hooker GW, Peay H, Erby L, Bayless T, Biesecker BB, Roter DL. Genetic literacy and patient perceptions of IBD testing utility and disease control: a randomized vignette study of genetic testing. Inflamm Bowel Dis. 2014;20:901–8.
Google Scholar
Milo Rasouly H, Cuneo N, Marasa M, DeMaria N, Chatterjee D, Thompson JJ, et al. GeneLiFT: A novel test to facilitate rapid screening of genetic literacy in a diverse population undergoing genetic testing. J Genet Couns. 2021;30:742–54.
Google Scholar
Osei, Jeffery. Polygenic Risk Scores in Clinical Practice? Still Making the Case [Internet]. Genomic and Precision Health. https://blogs.cdc.gov/genomics/2022/07/05/polygenic-risk-scores/
Wand H, Lambert SA, Tamburro C, Iacocca MA, O’Sullivan JW, Sillari C, et al. Improving reporting standards for polygenic scores in risk prediction studies. Nature. 2021;591:211–9.
Google Scholar
Prior L, Wood F, Gray J, Pill R, Hughes D. Making risk visible: The role of images in the assessment of (cancer) genetic risk. Health Risk Soc. 2002;4:241–58.
Google Scholar
Walter FM. Lay Understanding of Familial Risk of Common Chronic Diseases: A Systematic Review and Synthesis of Qualitative Research. Ann Fam Med. 2004 ;2:583–94.
Google Scholar
Wöhlke S, Schaper M, Schicktanz S. How Uncertainty Influences Lay People’s Attitudes and Risk Perceptions Concerning Predictive Genetic Testing and Risk Communication. Front Genet. 2019;10:380.
Google Scholar
Engelhardt EG, Pieterse AH, Han PKJ, Van Duijn-Bakker N, Cluitmans F, Maartense E, et al. Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer: Current Practices and Patients’ Perceptions of Uncertainty. Med Decis Mak. 2017;37:179–92.
Google Scholar
Burns C, James C, Ingles J. Communication of genetic information to families with inherited rhythm disorders. Heart Rhythm. 2018;15:780–6.
Google Scholar
Platt J. A Person-Centered Approach to Cardiovascular Genetic Testing. Cold Spring Harb Perspect Med. 2020;10:a036624.
Google Scholar
Lautenbach DM, Christensen KD, Sparks JA, Green RC. Communicating genetic risk information for common disorders in the era of genomic medicine. Annu Rev Genomics Hum Genet. 2013;14:491–513.
Google Scholar
Hamilton KV, Fox LC, Nichols KE How I Communicate with Patients and Families about Germline Genetic Information. Blood. 2023;blood.2022017379.
Law JH, Sultan N, Finer S, Fudge N. Advancing the communication of genetic risk for cardiometabolic diseases: a critical interpretive synthesis. BMC Med. 2023;21:432.
Google Scholar
Eckman MH, Wise RE, Naylor K, Arduser L, Lip GYH, Kissela B, et al. Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making. Curr Med Res Opin. 2015;31:603–14.
Google Scholar
Wang PJ, Lu Y, Mahaffey KW, Lin A, Morin DP, Sears SF, et al. Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision‐Making Pathway. J Am Heart Assoc. 2023;12:e028562.
Google Scholar
Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019;51:584–91.
Google Scholar
link
More Stories
Veterinary DNA Testing Market Size
KFSHRC Achieves 39% Rise in
Genomic screening reveals hidden health risks of patients